Clinical development of intramuscular electroporation: providing a "boost" for DNA vaccines
- PMID: 24510832
- DOI: 10.1007/978-1-4614-9632-8_25
Clinical development of intramuscular electroporation: providing a "boost" for DNA vaccines
Abstract
The development of effective vaccines has helped to eradicate or control the spread of numerous infectious diseases. However, there are many more diseases that have proved more difficult to eliminate using conventional vaccines. The recent innovation of DNA vaccines may provide a "boost" to the development efforts. While the early efforts of DNA vaccines in the clinic were disappointing, the use of in vivo electroporation has helped to provide some basis for optimism. Now, there are several ongoing clinical studies of vaccines against such diseases as malaria, HIV, hepatitis C, and even various types of cancer. This review will highlight three recently published clinical studies using intramuscular DNA administration with electroporation.
Similar articles
-
Electroporation-mediated administration of candidate DNA vaccines against HIV-1.Methods Mol Biol. 2014;1121:291-307. doi: 10.1007/978-1-4614-9632-8_26. Methods Mol Biol. 2014. PMID: 24510833 Review.
-
Enhancement of DNA vaccine potency in rhesus macaques by electroporation.Vaccine. 2004 Jun 23;22(19):2489-93. doi: 10.1016/j.vaccine.2003.11.073. Vaccine. 2004. PMID: 15193413
-
Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation.Vaccine. 2007 Sep 4;25(36):6635-45. doi: 10.1016/j.vaccine.2007.06.036. Epub 2007 Jul 10. Vaccine. 2007. PMID: 17669562
-
Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?Drug News Perspect. 2010 Dec;23(10):647-53. doi: 10.1358/dnp.2010.23.10.1513492. Drug News Perspect. 2010. PMID: 21180650 Review.
-
Electroporation-enhanced delivery of nucleic acid vaccines.Expert Rev Vaccines. 2015 Feb;14(2):195-204. doi: 10.1586/14760584.2015.990890. Epub 2014 Dec 9. Expert Rev Vaccines. 2015. PMID: 25487734 Review.
Cited by
-
HIV Env conserved element DNA vaccine alters immunodominance in macaques.Hum Vaccin Immunother. 2017 Dec 2;13(12):2859-2871. doi: 10.1080/21645515.2017.1339852. Epub 2017 Jul 5. Hum Vaccin Immunother. 2017. PMID: 28678607 Free PMC article.
-
Trial watch: Naked and vectored DNA-based anticancer vaccines.Oncoimmunology. 2015 Apr 2;4(5):e1026531. doi: 10.1080/2162402X.2015.1026531. eCollection 2015 May. Oncoimmunology. 2015. PMID: 26155408 Free PMC article.
-
DNA vaccines: prime time is now.Curr Opin Immunol. 2020 Aug;65:21-27. doi: 10.1016/j.coi.2020.01.006. Epub 2020 Apr 4. Curr Opin Immunol. 2020. PMID: 32259744 Free PMC article. Review.
-
DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response.PLoS One. 2018 Jun 4;13(6):e0197902. doi: 10.1371/journal.pone.0197902. eCollection 2018. PLoS One. 2018. PMID: 29864114 Free PMC article.
-
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults.Vaccines (Basel). 2020 Dec 7;8(4):741. doi: 10.3390/vaccines8040741. Vaccines (Basel). 2020. PMID: 33297341 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical